(VIANEWS) – SPBK 1 NORDMØRE (SNOR.OL), SPBK 1 ØSTLANDET (SPOL.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK 1 NORDMØRE (SNOR.OL)
25.4% sales growth and 8.68% return on equity
SpareBank 1 Nordmøre provides various banking services in Norway. The company provides business insurance products, including liability, work machine, condominium, car, bus, boat, cyber, crime, truck, property, commercial building, project, trailer, and transport insurance; personal insurance products, such as life, business, travel, and accidental insurance products; pension products; bank cards; payment and debt collection services; and mobile and online banking services. It also offers bank guarantees, operating credit products for agriculture, and factoring and leasing products and services, as well as savings and deposit accounts, refinancing, and mortgage services. The company was founded in 1835 and is based in Kristiansund, Norway. SpareBank 1 Nordmøre is a subsidiary of SpareBank 1 Gruppen AS.
Earnings Per Share
As for profitability, SPBK 1 NORDMØRE has a trailing twelve months EPS of kr12.61.
PE Ratio
SPBK 1 NORDMØRE has a trailing twelve months price to earnings ratio of 9.52. Meaning, the purchaser of the share is investing kr9.52 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.68%.
Yearly Top and Bottom Value
SPBK 1 NORDMØRE’s stock is valued at kr120.00 at 12:20 EST, way below its 52-week high of kr135.00 and above its 52-week low of kr117.00.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.1%, now sitting on 763M for the twelve trailing months.
Sales Growth
SPBK 1 NORDMØRE’s sales growth is 34.4% for the ongoing quarter and 25.4% for the next.
Moving Average
SPBK 1 NORDMØRE’s worth is below its 50-day moving average of kr121.02 and below its 200-day moving average of kr123.79.
More news about SPBK 1 NORDMØRE.
2. SPBK 1 ØSTLANDET (SPOL.OL)
20.3% sales growth and 11.87% return on equity
SpareBank 1 Østlandet provides various financial products and services to individuals, businesses, the public sector, clubs, and societies. The company operates through Retail, Corporate, and Organisation Market and Capital Market segments. The Retail segment provides financial services comprising of savings, money transfer, insurance, accident prevention, financing, money transfer, capital, and investment management services. The Corporate segment offers interest rate, currency hedging, and investment related services, as well as insurance services for property. The Organisation Market and Capital Market segment provides risk based advisory solutions to high-net-worth individuals and corporates, as well as engages in foreign currency services. SpareBank 1 Østlandet was founded in 1845 and is headquartered in Hamar, Norway. SpareBank 1 Østlandet operates as a subsidiary of Sparebankstiftelsen Hedmark.
Earnings Per Share
As for profitability, SPBK 1 ØSTLANDET has a trailing twelve months EPS of kr13.36.
PE Ratio
SPBK 1 ØSTLANDET has a trailing twelve months price to earnings ratio of 9.61. Meaning, the purchaser of the share is investing kr9.61 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.87%.
Volume
Today’s last reported volume for SPBK 1 ØSTLANDET is 10552 which is 65% below its average volume of 30157.
More news about SPBK 1 ØSTLANDET.
3. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.44. Meaning, the purchaser of the share is investing kr31.44 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.10 at 12:20 EST, way under its 52-week high of kr43.90 and way higher than its 52-week low of kr31.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
More news about NAVAMEDIC.
4. VOSS VEKSEL OGLAND (VVL.OL)
16% sales growth and 9.14% return on equity
Voss Veksel- og Landmandsbank ASA provides banking products and services to private individuals and companies in Norway. The company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. The company was founded in 1843 and is based in Voss, Norway.
Earnings Per Share
As for profitability, VOSS VEKSEL OGLAND has a trailing twelve months EPS of kr26.34.
PE Ratio
VOSS VEKSEL OGLAND has a trailing twelve months price to earnings ratio of 8.2. Meaning, the purchaser of the share is investing kr8.2 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.14%.
Sales Growth
VOSS VEKSEL OGLAND’s sales growth for the next quarter is 16%.
Moving Average
VOSS VEKSEL OGLAND’s value is below its 50-day moving average of kr233.96 and under its 200-day moving average of kr221.18.
More news about VOSS VEKSEL OGLAND.
5. SKUE SPAREBANK (SKUE.OL)
11.9% sales growth and 9.5% return on equity
Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, personal, vehicle, and small loans, as well as mortgage, bank guarantee, overdraft, and leasing services; and home and leisure, car and other vehicles, pet, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.
Earnings Per Share
As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr85.05.
PE Ratio
SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.59. Meaning, the purchaser of the share is investing kr2.59 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.
Sales Growth
SKUE SPAREBANK’s sales growth for the next quarter is 11.9%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 31.5% and 29.2%, respectively.
Volume
Today’s last reported volume for SKUE SPAREBANK is 279 which is 49.08% below its average volume of 548.
More news about SKUE SPAREBANK.
